Ionis Pharmaceuticals Inc (NASDAQ:IONS)

47.15
BATS BZX Real-Time Price
As of 3:57pm ET
 +0.87 / +1.88%
Today’s Change
32.69
Today|||52-Week Range
47.74
+24.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$6.1B

Company Description

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Contact Information

Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:

Employees

Shareholders

Mutual fund holders59.17%
Other institutional35.79%
Individual stakeholders1.13%

Top Executives

Brett P. MoniaChief Executive Officer & Director
Onaiza Cadoret-ManierEVP, Chief Product Strategy & Operations Officer
Elizabeth L. HougenChief Financial Officer & Executive VP-Finance
C. Frank BennettChief Scientific Officer & Executive VP
Sanjay BhanotChief Medical Officer & SVP